Bank of New York Mellon CorpBank of New York Mellon Corp

Institutional investor · Portfolio as of Q3 2024

SEC EDGAR SourceSEC Filings

Top Holdings4,093 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

61.8M$26.6B4.9%$212.91+99.16%
16 qtrssince 2020-Q4
Decreased
0

APPLE INC

109.7M$25.6B4.8%$128.82+79.38%
16 qtrssince 2020-Q4
Decreased
0

NVIDIA CORP

175M$21.2B4.0%$112.56+7.82%
16 qtrssince 2020-Q4
Decreased
0

AMAZON.COM INC

66.5M$12.4B2.3%$112.08+67.71%
16 qtrssince 2020-Q4
Decreased
0

META PLATFORMS INC-CLASS A

14.6M$8.3B1.5%$264.23+113.87%
16 qtrssince 2020-Q4
Decreased
0
IVVIVV
ETF

ISHARES CORE S&P 500 ETF

13.7M$7.9B1.5%$392.35+43.96%
16 qtrssince 2020-Q4
Increased
50

ALPHABET INC-CL A

46.6M$7.7B1.4%$96.58+68.90%
16 qtrssince 2020-Q4
Decreased
0

ALPHABET INC-CL C

44.5M$7.4B1.4%$96.80+69.90%
16 qtrssince 2020-Q4
Decreased
0

BROADCOM INC

36.5M$6.3B1.2%$157.55+8.34%
16 qtrssince 2020-Q4
Increased
81

BERKSHIRE HATHAWAY INC-CL B

12.6M$5.8B1.1%$234.35+95.21%
16 qtrssince 2020-Q4
Decreased
0

JPMORGAN CHASE & CO

25.2M$5.3B1.0%$111.82+82.40%
16 qtrssince 2020-Q4
Decreased
0

ELI LILLY & CO

6M$5.3B1.0%$169.37+415.85%
16 qtrssince 2020-Q4
Decreased
0

MASTERCARD INC - A

9.4M$4.6B0.9%$344.25+42.17%
16 qtrssince 2020-Q4
Decreased
0

UNITEDHEALTH GROUP INC

7.9M$4.6B0.9%$330.87+70.97%
16 qtrssince 2020-Q4
Decreased
0

EXXON MOBIL CORP

38.4M$4.5B0.8%$45.85+140.09%
16 qtrssince 2020-Q4
Decreased
0

TESLA INC

17.2M$4.5B0.8%$256.37+1.60%
16 qtrssince 2020-Q4
Decreased
0

COSTCO WHOLESALE CORP

4.5M$4B0.7%$382.80+129.07%
16 qtrssince 2020-Q4
Decreased
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

22.6M$3.9B0.7%$99.95+75.14%
16 qtrssince 2020-Q4
Decreased
0

CISCO SYSTEMS INC

72.1M$3.8B0.7%$39.02+30.74%
16 qtrssince 2020-Q4
Increased
46

PROCTER & GAMBLE CO/THE

20M$3.5B0.6%$121.26+35.33%
16 qtrssince 2020-Q4
Decreased
0
$537.7B
AUM
4,093
Positions
Q3 2024
Filing
Rating · 3.0
Quarterly Portfolio Change
+4%Q2'23$476.4B-4%Q3'23$455B+8%Q4'23$493.3B+6%Q1'24$520.7B+1%Q2'24$527.5B+2%Q3'24$537.7B
Activity profile
$ moved · Q3'24
New4%Increased22%Decreased71%Exited3%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.2 years
<1Q2%1-4Q5%1-2Y6%2Y+87%

Bank of New York Mellon Corp manages $537.7B across 4093 positions as of Q3 2024. Top holdings: MSFT (4.9%), AAPL (4.8%), NVDA (4.0%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3/5.0.

Q3 2024 Summary

Active quarter - 107 new positions, 139 exits, 726 increased. Top move: AVGO (INCREASED, conviction 81). Portfolio: $537.7B across 4093 positions.

Top holdings by portfolio weight

Total AUM$538B
MSFT4.95%
AAPL4.75%
NVDA3.95%
AMZN2.31%
META1.55%
IVV1.47%
GOOGL1.44%
GOOG1.38%
AVGO1.17%
BRK/B1.08%
Other0.99%

Portfolio allocation by GICS sector

Sectors11
Technology27.14%
Financial Services11.95%
Healthcare11.79%
Consumer Cyclical9.49%
Industrials8.94%
Unknown8.39%
Communication Services6.84%
Consumer Defensive4.96%
Energy3.68%
Basic Materials2.45%
Other4.37%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Financial Services, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Solid(3.0 / 5.0)
Track RecordNo data
Conviction39
Concentration38
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
AVEMAVEMAVANTIS EMERGING MARKETS EQ
Q3 2024 Q2 2026+2.6M shares+$256.3M
8Q
AVDEAVDEAMERICAN CENTY ETF TR
Q3 2024 Q2 2026+4.2M shares+$376.2M
8Q
FDGFDGAMERICAN CENTURY FOCUSED DYNAMIC GROWTH ETF
Q3 2024 Q2 2026+160,080 shares+$26.6M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used